Comera Life Sciences Holdings, Inc.
Symbol: CMRA
NASDAQ
0.02684
USDDzisiejsza cena rynkowa
-0.0074
Wskaźnik P/E
0.0000
Wskaźnik PEG
0.83M
Kapitalizacja MRK
- 0.00%
Rentowność DIV
Comera Life Sciences Holdings, Inc. (CMRA) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 0.4 | 6.5 | 0.2 | |||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.net-receivables | 0 | 0 | 0.2 | 0.1 | |||
balance-sheet.row.inventory | 0 | 2.5 | 0 | 0 | |||
balance-sheet.row.other-current-assets | 0 | 0.1 | 0 | 0 | |||
balance-sheet.row.total-current-assets | 0 | 3.1 | 6.8 | 0.3 | |||
balance-sheet.row.property-plant-equipment-net | 0 | 0.6 | 0.6 | 0.2 | |||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.other-non-current-assets | 0 | 0.1 | 0.1 | 0.1 | |||
balance-sheet.row.total-non-current-assets | 0 | 0.7 | 0.6 | 0.2 | |||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-assets | 0 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.account-payables | 0 | 1.5 | 0.4 | 0.1 | |||
balance-sheet.row.short-term-debt | 0 | 0.7 | 0.1 | 0.1 | |||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | |||
balance-sheet.row.long-term-debt-total | 0 | 0.1 | 0.2 | 0.2 | |||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | |||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||
balance-sheet.row.other-current-liab | 0 | 2.8 | 0 | 0 | |||
balance-sheet.row.total-non-current-liabilities | 0 | 4.9 | 21.1 | 0.2 | |||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||
balance-sheet.row.capital-lease-obligations | 0 | 0.3 | 0.3 | 0 | |||
balance-sheet.row.total-liab | 0 | 10 | 22.1 | 0.4 | |||
balance-sheet.row.preferred-stock | 0 | 4517.7 | 20.9 | 0 | |||
balance-sheet.row.common-stock | 0 | 0 | 0 | 10.7 | |||
balance-sheet.row.retained-earnings | 0 | -34.9 | -16.9 | -11.4 | |||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -20.9 | 0 | |||
balance-sheet.row.other-total-stockholders-equity | 0 | -4489.1 | 2.2 | 0.9 | |||
balance-sheet.row.total-stockholders-equity | 0 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 3.7 | 7.4 | 0.5 | |||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-equity | 0 | -6.2 | -14.7 | 0.2 | |||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||
Total Investments | 0 | 0 | 0 | 0 | |||
balance-sheet.row.total-debt | 0 | 0.8 | 0.3 | 0.2 | |||
balance-sheet.row.net-debt | 0 | 0.3 | -6.2 | 0 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -18 | -5.5 | -2.1 | |||
cash-flows.row.depreciation-and-amortization | 0 | 0.1 | 0.1 | 0.1 | |||
cash-flows.row.deferred-income-tax | 0 | 0 | -0.2 | 0 | |||
cash-flows.row.stock-based-compensation | 0 | 0.4 | 1.1 | 0.1 | |||
cash-flows.row.change-in-working-capital | 0 | 2.6 | 0.6 | 0 | |||
cash-flows.row.account-receivables | 0 | 0 | 0.1 | -0.1 | |||
cash-flows.row.inventory | 0 | 0 | 0.2 | 0.1 | |||
cash-flows.row.account-payables | 0 | 0.9 | 0.3 | 0 | |||
cash-flows.row.other-working-capital | 0 | 1.7 | 0 | 0 | |||
cash-flows.row.other-non-cash-items | 0 | 5.2 | 0.1 | 0.2 | |||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | |||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | |||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | |||
cash-flows.row.common-stock-issued | 0 | 0.8 | 0 | 1.4 | |||
cash-flows.row.common-stock-repurchased | 0 | 650 | 0 | 0 | |||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||
cash-flows.row.other-financing-activites | 0 | -645.6 | 10.3 | 0.2 | |||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 5.2 | 10.3 | 1.6 | |||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||
cash-flows.row.net-change-in-cash | 0 | -4.6 | 6.4 | -0.3 | |||
cash-flows.row.cash-at-end-of-period | 0 | 2 | 6.6 | 0.2 | |||
cash-flows.row.cash-at-beginning-of-period | 0 | 6.6 | 0.2 | 0.4 | |||
cash-flows.row.operating-cash-flow | 0 | -9.8 | -3.8 | -1.8 | |||
cash-flows.row.capital-expenditure | 0 | 0 | -0.1 | 0 | |||
cash-flows.row.free-cash-flow | 0 | -9.8 | -3.9 | -1.8 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | |||
---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0.6 | 0.3 | 0.4 | |||
income-statement-row.row.cost-of-revenue | 0 | 0.2 | 0.2 | 0.1 | |||
income-statement-row.row.gross-profit | 0 | 0.4 | 0.2 | 0.3 | |||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||
income-statement-row.row.research-development | 0 | - | - | - | |||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.other-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.operating-expenses | 0 | 12.4 | 5.7 | 2.5 | |||
income-statement-row.row.cost-and-expenses | 0 | 12.6 | 5.9 | 2.6 | |||
income-statement-row.row.interest-income | 0 | 0 | 0 | 0 | |||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | |||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||
income-statement-row.row.total-other-income-expensenet | 0 | -6 | 0.1 | 0 | |||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||
income-statement-row.row.other-operating-expenses | 0 | -1.5 | -0.1 | 0 | |||
income-statement-row.row.total-operating-expenses | 0 | -6 | 0.1 | 0 | |||
income-statement-row.row.interest-expense | 0 | 0 | 0 | 0 | |||
income-statement-row.row.depreciation-and-amortization | 0 | -1.4 | -0.1 | 0.1 | |||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||
income-statement-row.row.operating-income | 0 | -12 | -5.5 | -2.1 | |||
income-statement-row.row.income-before-tax | 0 | -18 | -5.5 | -2.1 | |||
income-statement-row.row.income-tax-expense | 0 | 6 | -0.2 | 0 | |||
income-statement-row.row.net-income | 0 | -24 | -5.3 | -2.1 |
Często zadawane pytania
Ile wynosi Comera Life Sciences Holdings, Inc. (CMRA) aktywów ogółem?
Comera Life Sciences Holdings, Inc. (CMRA) całkowite aktywa to 3727113.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to N/A.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.735.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to -1.529.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to -84.219.
Jaki jest całkowity przychód firmy?
Całkowity przychód to -9.143.
Co to jest Comera Life Sciences Holdings, Inc. (CMRA) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi -24038181.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 775048.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 12392727.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 0.000.